The Role of <sup>18</sup>F-FDG-PET/CT in the Management of Patients with High-Risk Breast Cancer: Case Series and Guideline Comparison
Advances in Molecular Imaging · 2014
DOI: 10.4236/ami.2014.43005 ↗Kurz gefasst
Leitlinie in der Zeitschrift Advances in Molecular Imaging, 2014. Verfasst von Ben F. Bulten und 8 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bulten, B. F., Haas, M. J. D., Bloemendal, H. J., Overbeeke, A. J. V., Esser, J. P., Baarslag, H. J., Geus-Oei, L. D., Rodenburg, C. J., & Klerk, J. M. H. D. (2014). The Role of 18F-FDG-PET/CT in the Management of Patients with High-Risk Breast Cancer: Case Series and Guideline Comparison. Advances in Molecular Imaging. https://doi.org/10.4236/ami.2014.43005
Vancouver
Bulten BF, Haas MJD, Bloemendal HJ, Overbeeke AJV, Esser JP, Baarslag HJ, et al. The Role of 18F-FDG-PET/CT in the Management of Patients with High-Risk Breast Cancer: Case Series and Guideline Comparison. Advances in Molecular Imaging. 2014. doi:10.4236/ami.2014.43005
BibTeX
@article{Bulten2014,
author = {Bulten, Ben F. and Haas, Marie J. de and Bloemendal, Haiko J. and Overbeeke, Adriaan J. van and Esser, Jan Paul and Baarslag, Henk J. and Geus-Oei, Lioe-Fee de and Rodenburg, C. J. and Klerk, John M. H. de},
title = {The Role of 18F-FDG-PET/CT in the Management of Patients with High-Risk Breast Cancer: Case Series and Guideline Comparison},
journal = {Advances in Molecular Imaging},
year = {2014},
doi = {10.4236/ami.2014.43005}
}
EUVIMED